The Ethics of Controlled Human Infection Trials in COVID-19 Research
Presenter Biography
The authors of this presentation are undergraduate or post bac students at Portland State University. The following presentation was a final for PHE 369- Public Health Law, Policy, and Ethics and highlights the ethical background and considerations behind controlled human infection trials, specifically in COVID-19 vaccine research.
Institution
PSU
Program/Major
Community Health Promotion
Degree
BS
Presentation Type
Poster
Start Date
4-8-2021 10:56 AM
End Date
4-8-2021 11:01 AM
Persistent Identifier
https://archives.pdx.edu/ds/psu/35579
Keywords
COVID-19, CHIs, Medical Ethics
Abstract
The use of CHIs to speed up COVID-19 vaccine research is something that has been approved by ethics committees in the UK. The purpose of this presentation is to break down the ethics behind these trials, weight the potential risks and benefits of them, and compare it to any prior research. Due to the uncertainty of how COVID-19 effects different people, the risks are hard to quantify, even in young, healthy individuals. Overall, without closer, more in depth research of this virus, understanding of its effects is unlikely. However, how much do you risk in order to achieve these benefits?
The Ethics of Controlled Human Infection Trials in COVID-19 Research
The use of CHIs to speed up COVID-19 vaccine research is something that has been approved by ethics committees in the UK. The purpose of this presentation is to break down the ethics behind these trials, weight the potential risks and benefits of them, and compare it to any prior research. Due to the uncertainty of how COVID-19 effects different people, the risks are hard to quantify, even in young, healthy individuals. Overall, without closer, more in depth research of this virus, understanding of its effects is unlikely. However, how much do you risk in order to achieve these benefits?